Details of the Drug Formulaction

General Information of Drug Formulation (ID: F22631)

• Formulation Name: Warfarin 4 mg tablet
• Company: Bristol-Myers Squibb Company

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Warfarin	(DMJYCVW)	Atrial fibrillation	BC81.3	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Aluminum trihydroxide	(E00505)	10176082	Alkalizing agent; Vaccine adjuvant
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
FD&C blue no. 1	(E00263)	19700	Colorant
Magnesium stearate	(E00208)	11177	lubricant